| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 1011 |
| 1 | METHOTREXATE | 811 |
| 2 | CYTARABINE | 369 |
| 3 | CYCLOPHOSPHAMIDE | 300 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 300 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 300 |
| 6 | DEXAMETHASONE | 221 |
| 7 | DEXAMETHASONE 1.5 MG | 221 |
| 8 | TACROLIMUS | 185 |
| 9 | RITUXIMAB | 171 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NELARABINE | 20 | 0.0205 |
| 1 | CLOTRIMAZOLE1% CLOTRIMAZOLE | 1 | 0.0182 |
| 2 | COCAINE HYDROCHLORIDE NASAL | 1 | 0.0154 |
| 3 | AESCULUS HIPPOCASTANUM WHOLE | 1 | 0.0133 |
| 4 | AGRIMONIA EUPATORIA | 1 | 0.0132 |
| 5 | CENTAURIUM ERYTHRAEA | 1 | 0.0130 |
| 6 | NITROUS OXIDE | 23 | 0.0104 |
| 7 | THIOGUANINE | 18 | 0.0085 |
| 8 | ALITRETINOIN | 1 | 0.0084 |
| 9 | BENZETHONIUM CHLORIDE | 1 | 0.0078 |
| # | Drug class | Count |
|---|---|---|
| 0 | Folate Analog Metabolic Inhibitor [EPC] | 818 |
| 1 | Corticosteroid [EPC] | 693 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 659 |
| 3 | Alkylating Drug [EPC] | 429 |
| 4 | Platinum-based Drug [EPC] | 315 |
| 5 | Benzodiazepine [EPC] | 205 |
| 6 | Opioid Agonist [EPC] | 183 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 174 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 171 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 169 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Growth Factor [EPC] | 9 | 0.0071 |
| 1 | Methylating Agent [EPC] | 5 | 0.0048 |
| 2 | Asparagine-specific Enzyme [EPC] | 63 | 0.0047 |
| 3 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 15 | 0.0046 |
| 4 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 4 | 0.0031 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 659 | 0.0024 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 818 | 0.0019 |
| 7 | Alkylating Drug [EPC] | 429 | 0.0018 |
| 8 | Topoisomerase Inhibitor [EPC] | 123 | 0.0016 |
| 9 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |